AstraZeneca executives at earnings conference, February 2020 (Natalie Grover for Endpoints News)

Coro­n­avirus out­break clouds As­traZeneca's Q4 re­sults and 2020 out­look

LON­DON — With near­ly a fifth of to­tal sales com­ing from Chi­na, As­traZeneca counts the coro­n­avirus-hit na­tion as one of its biggest growth dri­vers. The …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.